Veracyte Inc

Veracyte insider buys signal confidence in its oncology‑diagnostics pipeline and market strategy, offering investors a subtle bullish cue amid stable pricing and growing P/E.

Insider sales at Veracyte stay steady, with senior execs trading modestly—no signs of panic or buy‑spree, reflecting confidence in future growth.